• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

餐后肠道激素与骨重塑标志物之间的关联。

Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.

机构信息

Clinical Prevention Research, Steno Diabetes Center Copenhagen, 2820 Gentofte, Denmark.

Department of Clinical Medicine, Aalborg University, 9000 Aalborg, Denmark.

出版信息

Nutrients. 2021 Sep 14;13(9):3197. doi: 10.3390/nu13093197.

DOI:10.3390/nu13093197
PMID:34579074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8467604/
Abstract

Gut-derived hormones have been suggested to play a role in bone homeostasis following food intake, although the associations are highly complex and not fully understood. In a randomized, two-day cross-over study on 14 healthy individuals, we performed postprandial time-course studies to examine the associations of the bone remodeling markers carboxyl-terminal collagen type I crosslinks (CTX) and procollagen type 1 N-terminal propeptide (P1NP) with the gut hormones glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and peptide YY (PYY) using two different meal types-a standardized mixed meal (498 kcal) or a granola bar (260 kcal). Plasma concentrations of total GIP, total GLP-1, total PYY, CTX, and P1NP were measured up to 240 min after meal intake, and the incremental area under the curve (iAUC) for each marker was calculated. The iAUC of CTX and P1NP were used to assess associations with the iAUC of GIP, GLP-1, and PYY in linear mixed effect models adjusted for meal type. CTX was positively associated with GIP and GLP-1, and it was inversely associated with PYY (all < 0.001). No associations of P1NP with GIP or GLP-1 and PYY were found. In conclusion, the postprandial responses of the gut hormones GIP, GLP-1, and PYY are associated with the bone resorption marker CTX, supporting a link between gut hormones and bone homeostasis following food intake.

摘要

肠源激素被认为在进食后参与骨稳态的维持,尽管其相关性非常复杂且尚未完全阐明。在一项针对 14 名健康个体的随机、为期两天的交叉研究中,我们进行了餐后时间进程研究,以检查骨重塑标志物羧基末端 I 型胶原交联(CTX)和前胶原 I 型 N 端前肽(P1NP)与肠激素葡萄糖依赖性胰岛素释放肽(GIP)、胰高血糖素样肽 1(GLP-1)和肽 YY(PYY)之间的相关性,使用两种不同的餐型——标准化混合餐(498 千卡)或格兰诺拉麦片棒(260 千卡)。在进食后 240 分钟内测量了总 GIP、总 GLP-1、总 PYY、CTX 和 P1NP 的血浆浓度,并计算了每个标志物的增量曲线下面积(iAUC)。使用线性混合效应模型,根据餐型调整,将 CTX 和 P1NP 的 iAUC 与 GIP、GLP-1 和 PYY 的 iAUC 进行关联分析。CTX 与 GIP 和 GLP-1 呈正相关,与 PYY 呈负相关(均<0.001)。未发现 P1NP 与 GIP 或 GLP-1 和 PYY 之间存在相关性。总之,肠激素 GIP、GLP-1 和 PYY 的餐后反应与骨吸收标志物 CTX 相关,这支持了进食后肠激素与骨稳态之间的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a1/8467604/cbafbd89d747/nutrients-13-03197-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a1/8467604/cbafbd89d747/nutrients-13-03197-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a1/8467604/cbafbd89d747/nutrients-13-03197-g001.jpg

相似文献

1
Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.餐后肠道激素与骨重塑标志物之间的关联。
Nutrients. 2021 Sep 14;13(9):3197. doi: 10.3390/nu13093197.
2
The role of endogenous GIP and GLP-1 in postprandial bone homeostasis.内源性 GIP 和 GLP-1 在餐后骨稳态中的作用。
Bone. 2020 Nov;140:115553. doi: 10.1016/j.bone.2020.115553. Epub 2020 Jul 27.
3
Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state.健康志愿者空腹和餐后胃肠胰激素浓度的预期值。
Ann Clin Biochem. 2021 Mar;58(2):108-116. doi: 10.1177/0004563220975658. Epub 2020 Dec 7.
4
Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.静脉注射或口服葡萄糖对健康男性受试者骨转换标志物的不同影响。
Bone. 2017 Apr;97:261-266. doi: 10.1016/j.bone.2017.01.027. Epub 2017 Jan 23.
5
Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes.超重男性中 GIP 和 GLP-1 输注对骨代谢的单独和联合作用。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2953-2960. doi: 10.1210/jc.2019-00008.
6
Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.混合餐试验和静脉注射L-精氨酸试验均可刺激人体葡萄糖耐量过程中肠促胰岛素的释放:与β细胞功能缺乏相关性。
Metab Syndr Relat Disord. 2018 Oct;16(8):406-415. doi: 10.1089/met.2018.0022. Epub 2018 Aug 17.
7
Role of gastrointestinal hormones in postprandial reduction of bone resorption.胃肠激素在餐后骨吸收减少中的作用。
J Bone Miner Res. 2003 Dec;18(12):2180-9. doi: 10.1359/jbmr.2003.18.12.2180.
8
Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.二肽基肽酶 IV 抑制对健康男性脂肪引起的血糖、肠激素、甘油三酯、能量消耗和能量摄入反应的影响。
Am J Physiol Endocrinol Metab. 2014 Nov 1;307(9):E830-7. doi: 10.1152/ajpendo.00370.2014. Epub 2014 Sep 16.
9
Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: A preliminary study.皮下给予 GIP 和 GLP-2 可抑制绝经后妇女夜间骨吸收:一项初步研究。
Bone. 2021 Nov;152:116065. doi: 10.1016/j.bone.2021.116065. Epub 2021 Jun 19.
10
Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes.阿卡波糖可减轻 2 型糖尿病患者餐后骨吸收抑制作用。
Bone. 2023 May;170:116687. doi: 10.1016/j.bone.2023.116687. Epub 2023 Feb 6.

引用本文的文献

1
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).骨转换标志物在骨质疏松症诊断和管理中的作用更新:来自欧洲骨质疏松症、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)、国际骨质疏松症基金会(IOF)以及国际临床化学和检验医学联合会(IFCC)的共识文件。
Osteoporos Int. 2025 Apr;36(4):579-608. doi: 10.1007/s00198-025-07422-3. Epub 2025 Mar 28.
2
Changes Over Time in Masseter Muscle Activity, Symptoms of Discomfort, Stress Level and Salivary Flow Rate Following Intra-Oesophageal Acid Infusion.食管内酸灌注后咬肌活动、不适症状、压力水平和唾液流速随时间的变化
J Oral Rehabil. 2025 Mar;52(3):332-342. doi: 10.1111/joor.13905. Epub 2024 Nov 18.
3

本文引用的文献

1
Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood.分析要点及标准化或统一血 PINP 和β-CTX 等参考骨转换标志物检测方法的计划。
Clin Chim Acta. 2021 Apr;515:16-20. doi: 10.1016/j.cca.2020.12.023. Epub 2020 Dec 28.
2
Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes.葡萄糖依赖性促胰岛素多肽(GIP)可减少2型糖尿病患者的骨吸收。
J Endocr Soc. 2020 Jul 16;4(9):bvaa097. doi: 10.1210/jendso/bvaa097. eCollection 2020 Sep 1.
3
Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RESET) study.
The Temporal Change in Ionised Calcium, Parathyroid Hormone and Bone Metabolism Following Ingestion of a Plant-Sourced Marine Mineral + Protein Isolate in Healthy Young Adults.健康年轻成年人摄入植物源海洋矿物质+蛋白质分离物后,离子化钙、甲状旁腺激素和骨代谢的时间变化。
Nutrients. 2024 Sep 14;16(18):3110. doi: 10.3390/nu16183110.
4
Gut hormones and bone homeostasis: potential therapeutic implications.肠道激素与骨稳态:潜在的治疗意义。
Nat Rev Endocrinol. 2024 Sep;20(9):553-564. doi: 10.1038/s41574-024-01000-z. Epub 2024 Jun 10.
5
Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis.肠道激素对骨代谢的影响及其在骨质疏松症治疗中的可能机制。
Front Pharmacol. 2024 Apr 25;15:1372399. doi: 10.3389/fphar.2024.1372399. eCollection 2024.
6
Enhanced bone regeneration via endochondral ossification using Exendin-4-modified mesenchymal stem cells.使用艾塞那肽-4修饰的间充质干细胞通过软骨内成骨促进骨再生。
Bioact Mater. 2023 Dec 19;34:98-111. doi: 10.1016/j.bioactmat.2023.12.007. eCollection 2024 Apr.
7
Bone resorption and incretin hormones following glucose ingestion in healthy emerging adults.健康青年成人摄入葡萄糖后的骨吸收与肠促胰岛素激素
J Clin Transl Endocrinol. 2023 Feb 6;31:100314. doi: 10.1016/j.jcte.2023.100314. eCollection 2023 Mar.
8
The Gut-Bone Axis in Diabetes.糖尿病的肠-骨轴。
Curr Osteoporos Rep. 2023 Feb;21(1):21-31. doi: 10.1007/s11914-022-00767-2. Epub 2022 Nov 28.
9
The association between normal serum sodium levels and bone turnover in patients with type 2 diabetes.2 型糖尿病患者血清钠水平正常与骨转换的关系。
Front Endocrinol (Lausanne). 2022 Oct 27;13:927223. doi: 10.3389/fendo.2022.927223. eCollection 2022.
10
The PYY/Y2R-deficient male mouse is not protected from bone loss due to Roux-en-Y gastric bypass.PYY/Y2R 缺陷型雄性小鼠不能免受 Roux-en-Y 胃旁路术引起的骨丢失的影响。
Bone. 2023 Feb;167:116608. doi: 10.1016/j.bone.2022.116608. Epub 2022 Nov 8.
一项关于限时进食对2型糖尿病高危个体体重、行为和代谢影响的单中心、平行组、随机、对照、优效性试验方案:限时进食(RESET)研究
BMJ Open. 2020 Aug 26;10(8):e037166. doi: 10.1136/bmjopen-2020-037166.
4
A Short-Term Ketogenic Diet Impairs Markers of Bone Health in Response to Exercise.短期生酮饮食会削弱运动对骨骼健康的促进作用。
Front Endocrinol (Lausanne). 2020 Jan 21;10:880. doi: 10.3389/fendo.2019.00880. eCollection 2019.
5
Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity.腹部肥胖人群中,营养素的消耗和胰岛素抵抗会抑制骨转换标志物的生成。
Bone. 2020 Apr;133:115230. doi: 10.1016/j.bone.2020.115230. Epub 2020 Jan 15.
6
Increases in PYY and uncoupling of bone turnover are associated with loss of bone mass after gastric bypass surgery.胃旁路手术后 PYY 增加和骨转换偶联分离与骨量丢失有关。
Bone. 2020 Feb;131:115115. doi: 10.1016/j.bone.2019.115115. Epub 2019 Nov 2.
7
A Pilot Study Showing Acute Inhibitory Effect of GLP-1 on the Bone Resorption Marker CTX in Humans.一项初步研究显示GLP-1对人体骨吸收标志物CTX具有急性抑制作用。
JBMR Plus. 2019 Aug 23;3(10):e10209. doi: 10.1002/jbm4.10209. eCollection 2019 Oct.
8
GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH.GIP(葡萄糖依赖性促胰岛素多肽)受体选择性拮抗剂 GIP(3-30)NH 可降低 GIP 对骨代谢的作用。
Bone. 2020 Jan;130:115079. doi: 10.1016/j.bone.2019.115079. Epub 2019 Oct 14.
9
Effect of diabetes-specific nutrition formulas on satiety and hunger hormones in patients with type 2 diabetes.糖尿病特定营养配方对 2 型糖尿病患者饱腹感和饥饿激素的影响。
Nutr Diabetes. 2019 Sep 24;9(1):26. doi: 10.1038/s41387-019-0093-x.
10
PYY is a negative regulator of bone mass and strength.PYY 是骨量和骨强度的负调节剂。
Bone. 2019 Oct;127:427-435. doi: 10.1016/j.bone.2019.07.011. Epub 2019 Jul 12.